Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment and Tracking of Long-Term Alefacept (LFA-3/IgG1 Fusion Protein) Pregnancy Exposure Registry

NCT00342862 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00342862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00342862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment and Tracking of Long-Term Alefacept (LFA-3/IgG1 Fusion Protein) Pregnancy Exposure Registry
Lead sponsor
Astellas Pharma Inc
Phase
Observational
Overall status
Terminated
Start date
December 31, 2003
Completion date
December 31, 2011
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy